[HTML][HTML] Changes in the secretome of tri-dimensional spheroid-cultured human mesenchymal stem cells in vitro by interleukin-1 priming

E Redondo-Castro, CJ Cunningham, J Miller… - Stem cell research & …, 2018 - Springer
Abstract Background Mesenchymal stem cells (MSCs) are one of the most promising
candidates for the treatment of major neurological disorders. Desirable therapeutic …

[PDF][PDF] Changes in the secretome of tri-dimensional spheroid-cultured human mesenchymal stem cells in vitro by interleukin-1 priming

E Redondo-Castro, CJ Cunningham, J Miller, H Brown… - stroke, 2018 - sciencecat.co.uk
Abstract Background: Mesenchymal stem cells (MSCs) are one of the most promising
candidates for the treatment of major neurological disorders. Desirable therapeutic …

[PDF][PDF] Changes in the secretome of tri-dimensional spheroid-cultured human mesenchymal stem cells in vitro by interleukin-1 priming

E Redondo-Castro, CJ Cunningham, J Miller, H Brown… - stroke, 2018 - core.ac.uk
Abstract Background: Mesenchymal stem cells (MSCs) are one of the most promising
candidates for the treatment of major neurological disorders. Desirable therapeutic …

[HTML][HTML] Changes in the secretome of tri-dimensional spheroid-cultured human mesenchymal stem cells in vitro by interleukin-1 priming

E Redondo-Castro… - … Cell Research & …, 2018 - stemcellres.biomedcentral.com
Mesenchymal stem cells (MSCs) are one of the most promising candidates for the treatment
of major neurological disorders. Desirable therapeutic properties of MSCs include reparative …

[HTML][HTML] Changes in the secretome of tri-dimensional spheroid-cultured human mesenchymal stem cells in vitro by interleukin-1 priming

E Redondo-Castro, CJ Cunningham… - Stem Cell Research & …, 2018 - ncbi.nlm.nih.gov
Background Mesenchymal stem cells (MSCs) are one of the most promising candidates for
the treatment of major neurological disorders. Desirable therapeutic properties of MSCs …

Changes in the secretome of tri-dimensional spheroid-cultured human mesenchymal stem cells in vitro by interleukin-1 priming

E Redondo-Castro, CJ Cunningham, J Miller, H Brown… - 2018 - agris.fao.org
Abstract Background Mesenchymal stem cells (MSCs) are one of the most promising
candidates for the treatment of major neurological disorders. Desirable therapeutic …

Changes in the secretome of tri-dimensional spheroid-cultured human mesenchymal stem cells in vitro by interleukin-1 priming.

E Redondo-Castro, CJ Cunningham… - Stem Cell Research & …, 2018 - europepmc.org
BACKGROUND: Mesenchymal stem cells (MSCs) are one of the most promising candidates
for the treatment of major neurological disorders. Desirable therapeutic properties of MSCs …

Changes in the secretome of tri-dimensional spheroid-cultured human mesenchymal stem cells in vitro by interleukin-1 priming

E Redondo-Castro, C Cunningham… - Stem cell research …, 2018 - abdn.elsevierpure.com
Background Mesenchymal stem cells (MSCs) are one of the most promising candidates for
the treatment of major neurological disorders. Desirable therapeutic properties of MSCs …

[PDF][PDF] Changes in the secretome of tri-dimensional spheroid-cultured human mesenchymal stem cells in vitro by interleukin-1 priming

E Redondo-Castro, C Cunningham… - Stem cell research & …, 2018 - aura.abdn.ac.uk
Abstract Background: Mesenchymal stem cells (MSCs) are one of the most promising
candidates for the treatment of major neurological disorders. Desirable therapeutic …

[引用][C] Changes in the secretome of tri-dimensional spheroid-cultured human mesenchymal stem cells in vitro by interleukin-1 priming

E Redondo-Castro, CJ Cunningham, J Miller… - Stem Cell Research & …, 2018 - cir.nii.ac.jp
Changes in the secretome of tri-dimensional spheroid-cultured human mesenchymal stem
cells in vitro by interleukin-1 priming | CiNii Research CiNii 国立情報学研究所 学術情報 …